• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth

by Jasmine Pennic 06/03/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
PwC Report: 5 Key Actions for Pharma Companies to Drive Value Growth

What You Should Know:

– A new PwC report offers insights into how pharma companies can translate game-changing science into greater returns.

– Despite many major therapeutic advancements within the last decade, returns from pharma companies lagged the S&P 500 by about one-third and biotech underperformed by 60 percent. The stock performance divide between the front and back of the pack has been widening. PwC’s analysis showed that in 2021, the five-year total shareholder return for drugmakers in the top quintile was up by 29%, compared with a decline of 11% in the bottom quintile.

Key Actions for Pharma Leaders to Drive Value Growth

According to the report, leaders can gain a competitive advantage in the pursuit of higher shareholder returns by focusing on five key actions to drive value growth:

– Build differentiated capabilities (i.e. decentralized trials, machine learning at scale, digital innovation, etc.) to outperform the competition.

– Drive more returns from large IT and cloud investments – Capitalize on investments in AI, automation, and cloud to improve patient/customer satisfaction and efficiency.

– Retain talent and prioritize culture – In the age of ‘The Great Resignation’ and the ‘war for talent,’ having a differentiated culture is critical. Own ESG responsibilities, nurture a sense of belonging and trust, and create a culture rooted in innovation.

– Think broadly about portfolio and transactions –Given the competitive landscape and abundance of capital in the sector lately, revamp the business development process to drive more outcomes from your transactions.

– Protect the enterprise — Minimize any downside risk around cybersecurity, regulatory challenges, and legal matters to preserve value.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Biotech, cloud, Cybersecurity, digital innovation, Machine Learning, Pharma, PWC Report, risk

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |